Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
Clinical trial NCT05327270 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05327270
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2027-02-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.